data + articles · 5 listed
newest 2024spec sheet11 rows
Phentermine is a prescription appetite-suppressant stimulant and the most widely prescribed weight-loss drug; it is an amphetamine relative that curbs hunger by triggering the release of norepinephrine (and, more weakly, dopamine) in the brain, which the hypothalamus reads as fullness. It is used short-term for obesity, often paired with topiramate as the combination drug Qsymia.
- The most-prescribed weight-loss drug
- Curbs appetite via norepinephrine release
- Pairs with topiramate as Qsymia
- Much less euphoric/addictive than amphetamine
- Raised heart rate and blood pressure
- Insomnia, dry mouth, jitteriness
- Dependence potential with misuse
- Avoid with MAOIs and in heart disease
Mechanism
Phentermine is a substituted amphetamine (alpha,alpha-dimethylphenethylamine) that works mainly as a releasing agent; it makes nerve terminals dump norepinephrine, with weaker release, and the resulting signaling in the suppresses appetite. Unlike amphetamine it has little serotonergic action and is much less reinforcing or euphoric, which is why it is the anorectic that stuck around while more addictive ones were pulled.
receptor fingerprint
transporter (NET)releaser
()releaser
TAAR1agonist
Dosingtypical ranges, not medical advice
interested in protocols and clinical dosages? make an account to see them! ^_^
Safetyrisks and cautions, not medical advice
As a stimulant it raises heart rate and blood pressure and can cause insomnia, dry mouth, jitteriness, and, with misuse, dependence; it is meant for short-term use only. It must not be combined with MAOIs (risk of a hypertensive crisis) and is not for people with significant heart disease, uncontrolled hypertension, or hyperthyroidism. Not medical advice.
Interactionsdocumented pairs only, not exhaustive
Phentermine is a weak inhibitor of human monoamine oxidase A with a Ki of 498 microM, approximately 6-fold weaker than the rat enzyme and substantially weaker than classic MAO inhibitors like moclobemide [4]. In rat studies, phentermine showed MAO-A inhibition potency of 85-88 microM, placing it in the range of reversible MAO inhibitors, and when combined with other reversible MAO inhibitors such as pseudoephedrine or ephedrine, the degree of MAO inhibition was additive, though clinical relevance remains unclear [5]. Human enzyme kinetics indicate that phentermine's inhibition of both MAO-A and MAO-B is too weak to be of pharmacological importance at therapeutic doses [4]. Because phentermine is a sympathomimetic amine structurally related to amphetamine and methamphetamine, it can theoretically potentiate serotonergic agents; however, studies examining this interaction in humans are largely absent from the literature.
Phentermine's interactions with serotonin reuptake inhibitors remain inadequately studied despite historical concerns from the fen-phen era. The interaction with classic MAO inhibitors has never been formally documented, leaving a significant gap in the clinical evidence base.
Checking a whole stack? Run it through interactions + stacks.
Subjective profileweighing the evidence above
It works, and for short-term appetite control under a prescriber it is a reasonable tool, particularly paired with topiramate. Tolerance builds quickly, so it is not a long-term answer, and the faster heart rate, higher blood pressure and broken sleep rule it out for plenty of people. Not something to source outside a clinic.
Resources
This entry is here for reference.
Research
- 2000first citedUse of sibutramine and other noradrenergic and serotonergic drugs in the management of obesity.
- 2024most recentPhentermine in the Modern Era of Obesity Pharmacotherapy: Does It Still Have a Role in Treatmen…
- 1.Phentermine in the Modern Era of Obesity Pharmacotherapy: Does It Still Have a Role in Treatment?
- 2.Combination phentermine and topiramate extended release in the management of obesity.
- 3.Use of sibutramine and other noradrenergic and serotonergic drugs in the management of obesity.
- 4.Phentermine inhibition of recombinant human liver monoamine oxidases A and B.
- 5.Characterization of phentermine and related compounds as monoamine oxidase (MAO) inhibitors.
5 listed here; entry last updated July 2026
Reviews
My notesprivate to this device
FAQ
How does phentermine cause weight loss?
It releases norepinephrine (and some dopamine) in the brain, which suppresses appetite so you eat less; it does not burn fat directly.
Is it addictive like amphetamine?
It is chemically related but far less reinforcing and euphoric, which is why it remains available; misuse can still cause dependence.
What is Qsymia?
A combination of phentermine and topiramate used for chronic weight management; the two work through different mechanisms.
Adverse effects
- Raised heart rate and blood pressure
- Insomnia, dry mouth, jitteriness
- Dependence potential with misuse
- Avoid with MAOIs and in heart disease